SEC Form D · filed January 12, 2017
IRX Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (29)
John D. Halpern · New York, NYDirectorGeorge P. Denny Iii · New York, NYDirectorFerid D. Murad · New York, NYDirectorZygmund P. Roth · New York, NYExecCharles R. Cherington · New York, NYDirectorLawrence M. Wolf · New York, NYDirectorDavid H. Deming · New York, NYDirectorJohn W. Hadden Ii · New York, NYExec · DirectorJeffrey Hwang · New York, NYExecCurtis P. Robb · New York, NYExecPaul Lichty · Louisville, CODirectorJames Trevey · Louisville, COExec · DirectorBill Flecky · Louisville, COExecAlexandra Waldman · New York, NYDirectorJack Mcfarland · Louisville, CODirectorDavid King · Louisville, CODirectorBrad Beasecker · Columbus, OHDirectorDennis Townsend · Louisville, CODirectorGanesh H. Betanabhatla · Houston, TXExecJerod Bowen · Chandler, AZExecJared D. Levin · Richmond, VADirectorMax D. Comess · Richmond, VADirectorAileen S. O'Toole · Amsterdam, P7DirectorLawrence C. Illg · Incline Village, NVDirectorGary Rojewski · Las Vegas, NVExec · DirectorJohn D. Harper · Las Vegas, NVDirectorJohn W. Copeland · Palm Beach, FLDirectorRichard S. Berg · Chicago, ILExecDavid F. Wilding · Chicago, ILExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗